English  |  正體中文  |  简体中文  |  2823024  
???header.visitor??? :  30276259    ???header.onlineuser??? :  1207
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"tseng tseng t c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2022 Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents Huang, S.-C.;Cheng, P.-N.;Liu, C.-H.;Yang, H.-C.;Su, T.-H.;Tseng, Tseng T.-C.;Chen, P.-J.;Kao, J.-H.;Liu, C.-J.
國立成功大學 2022 The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan Lin, C.-L.;Tai, C.-M.;Huang, J.-F.;Liu, C.-J.;Chen, H.-F.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Wang, C.-C.;Weng, S.-H.;Tseng, Tseng T.-C.;Kao, J.-H.
國立成功大學 2020 High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy Chang, W.-Y.;Chiu, Y.-C.;Chiu, F.-W.;Hsu, Y.-C.;Tseng, Tseng T.-C.;Cheng, P.-N.;Yang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Liu, C.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.
國立成功大學 2017 Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells Lin, G.-L.;Ting, H.-J.;Tseng, Tseng T.-C.;Juang, V.;Lo, Y.-L.
國立政治大學 2015-01 What can we learn from hepatitis B virus clinical cohorts? Lin, Chih-Lin;Tseng, Tseng T.-C.;Kao, J.-H.; 林志陵

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page